Vineet Laboratories (NSE:VINEETLAB) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


NSE:VINEETLAB Vineet Laboratories Ltd NSE:VINEETLAB
38 GF Score
Price ₹34.00
GF Value ₹15.42
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Vineet Laboratories Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Vineet Laboratories's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NSE:VINEETLAB vs DOW: Margin of Safety % (DCF Earnings Based) Comparison

For the Chemicals subindustry, Vineet Laboratories's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vineet Laboratories Margin of Safety % (DCF Earnings Based) vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Vineet Laboratories's Margin of Safety % (DCF Earnings Based) falls into.


NSE:VINEETLAB
38GF Score
Vineet Laboratories Ltd NSE:VINEETLAB
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹34.00 is trading 120.5% above its estimated GF Value™ of ₹15.42. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹15.42 vs. price of ₹34.00 (120.5% above fair value)
  • GF Score™: 38/100 with 6 warning signs

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vineet Laboratories Business Description

Other Exchanges 543298:India
Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score

Get the complete analysis for NSE:VINEETLAB

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹34.00
Price
₹15.42
GF Value